arrow
H

Hiromichi Ebi

aichi cancer center research institute
H指数:42
被引数:8,598

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Targeting SUMOylation promotes cBAF complex stabilization and disruption of the SS18::SSX transcriptome in synovial sarcoma

靶向SUMOylation促进cBAF复合物的稳定化,并破坏滑膜肉瘤中SS18::SSX转录组。

2025-11-050
OAAI
Inhibiting KRAS with CD47 and immune checkpoint overcomes intrinsic resistance to combined KRAS and immune checkpoint inhibitor therapy

使用CD47和免疫检查点抑制KRAS可克服对联合KRAS和免疫检查点抑制剂疗法的固有耐药性

2025-08-290
OAAI
ctDNA-based molecular residual disease and survival in resectable colorectal cancer

可切除结直肠癌中基于ctDNA的分子残留疾病和生存

2024-09-161
OAAI
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer

泛亚适应ESMO临床实践指南,用于转移性结直肠癌患者的诊断,治疗和随访

2023-06-0123
OAAI
ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1
2022-07-0115
OA
Impact of plasma VEGF-A, VEGF-D and PlGF on the efficacy of 2nd-line chemotherapy combined with biologics in mCRC
2022-07-010
OAAI
Circulating tumor DNA-guided treatment with pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer: a phase 2 trial

循环肿瘤DNA指导下帕妥珠单抗联合曲妥珠单抗治疗HER2-amplified转移性结直肠癌的2期临床试验

2021-11-11129
OAAI